UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prediction of sensitivity to gefitinib/erlotinib for EGFR mutations in NSCLC based on structural interaction fingerprints and multilinear principal component analysis

BMC bioinformatics, 2018-03, Vol.19 (1), p.88-88, Article 88

2018

Volltextzugriff (PDF)

Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma

PloS one, 2016-06, Vol.11 (6), p.e0157969-e0157969

2016

Volltextzugriff (PDF)

Effectiveness and safety of continuous low-molecular-weight heparin versus switching to direct oral anticoagulants in cancer-associated venous thrombosis

Nature communications, 2024-07, Vol.15 (1), p.5657-11, Article 5657

2024

Volltextzugriff (PDF)

The Relationships Between Radiation Dosage and Long-term Swallowing Kinematics and Timing in Nasopharyngeal Carcinoma Survivors

Dysphagia, 2022-06, Vol.37 (3), p.612-621

2022

Volltextzugriff (PDF)

Contribution of EGFR and ErbB-3 Heterodimerization to the EGFR Mutation-Induced Gefitinib- and Erlotinib-Resistance in Non-Small-Cell Lung Carcinoma Treatments

PloS one, 2015-05, Vol.10 (5), p.e0128360-e0128360

2015

Volltextzugriff (PDF)

Safety of two-dose COVID-19 vaccination (BNT162b2 and CoronaVac) in adults with cancer: a territory-wide cohort study

Journal of hematology and oncology, 2022-05, Vol.15 (1), p.66-6, Article 66

2022

Volltextzugriff (PDF)

Long-term outcomes and recurrence pattern of 18F-FDG PET-CT complete metabolic response in the first-line treatment of metastatic colorectal cancer: a lesion-based and patient-based analysis

BMC cancer, 2018-07, Vol.18 (1), p.776-776, Article 776

2018

Volltextzugriff (PDF)

A systematic review and recommendations on the use of plasma EBV DNA for nasopharyngeal carcinoma

European journal of cancer (1990), 2021-08, Vol.153, p.109-122

2021

Volltextzugriff (PDF)

Dosimetric Predictors of Radiation-induced Acute Nausea and Vomiting in IMRT for Nasopharyngeal Cancer

International journal of radiation oncology, biology, physics, 2012-09, Vol.84 (1), p.176-182

2012

Volltextzugriff (PDF)

Deciphering mechanisms of acquired T790M mutation after EGFR inhibitors for NSCLC by computational simulations

Scientific reports, 2017-07, Vol.7 (1), p.6595-13, Article 6595

2017

Volltextzugriff (PDF)

Novel therapy for nasopharyngeal carcinoma – Where are we

Oral oncology, 2014-09, Vol.50 (9), p.798-801

2014

Volltextzugriff (PDF)

The Role of Natural Killer Cells in the Tumor Immune Microenvironment of EBV-Associated Nasopharyngeal Carcinoma

Cancers, 2024-04, Vol.16 (7), p.1312

2024

Volltextzugriff (PDF)

Patterns of care and treatment outcomes for local recurrence of NPC after definite IMRT—A study by the HKNPCSG

Head & neck, 2019-10, Vol.41 (10), p.3661-3669

2019

Volltextzugriff (PDF)

EGFR Mutant Structural Database: computationally predicted 3D structures and the corresponding binding free energies with gefitinib and erlotinib

BMC bioinformatics, 2015-03, Vol.16 (1), p.85-85, Article 85

2015

Volltextzugriff (PDF)

Cost-Effectiveness of Anti-Epidermal Growth Factor Receptor Therapy Versus Bevacizumab in KRAS Wild-Type (WT), Pan-RAS WT, and Pan-RAS WT Left-Sided Metastatic Colorectal Cancer

Frontiers in oncology, 2021-05, Vol.11, p.651299-651299

2021

Volltextzugriff (PDF)

Direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer-associated venous thrombosis: a cost-effectiveness analysis

Journal of pharmaceutical policy and practice, 2024-12, Vol.17 (1), p.2375269

2024

Volltextzugriff (PDF)

Application of Artificial Intelligence for Nasopharyngeal Carcinoma Management - A Systematic Review

Cancer management and research, 2022-01, Vol.14, p.339-366

2022

Volltextzugriff (PDF)

Molecular subtyping of cancer: current status and moving toward clinical applications

Briefings in bioinformatics, 2019-03, Vol.20 (2), p.572-584

2019

Volltextzugriff (PDF)

Clinical utility of plasma Epstein‐Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma

Cancer, 2015-08, Vol.121 (16), p.2720-2729

2015

Volltextzugriff (PDF)

Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma

Journal of hepatology, 2020-07, Vol.73 (1), p.121-129

2020

Volltextzugriff (PDF)

Whole-Field Simultaneous Integrated-Boost Intensity-Modulated Radiotherapy for Patients With Nasopharyngeal Carcinoma

International journal of radiation oncology, biology, physics, 2010-01, Vol.76 (1), p.138-145

2010

Volltextzugriff (PDF)

A Novel DPYD Variant Associated With Severe Toxicity of Fluoropyrimidines: Role of Pre-emptive DPYD Genotype Screening

Frontiers in oncology, 2018-07, Vol.8, p.279

2018

Volltextzugriff (PDF)

Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial

Journal of clinical oncology, 2018-11, Vol.36 (31), p.JCO2018777847-3100

2018

Volltextzugriff (PDF)

Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study)

Oral oncology, 2018-02, Vol.77, p.16-21

2018

Volltextzugriff (PDF)

Considerations for Use of Immune Checkpoint Inhibitors in Cancer Therapy for Patients with Co-Existing Thyroid Eye Disease

Ophthalmology and therapy, 2021-03, Vol.10 (1), p.5-12

2021

Volltextzugriff (PDF)

1 – 25 von 475

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(434)
Mit Volltextzugriff
(391)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Prediction of sensitivity to gefitinib/erlotinib for EGFR mutations in NSCLC based on structural interaction fingerprints and multilinear principal component analysis

Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma

Effectiveness and safety of continuous low-molecular-weight heparin versus switching to direct oral anticoagulants in cancer-associated venous thrombosis

The Relationships Between Radiation Dosage and Long-term Swallowing Kinematics and Timing in Nasopharyngeal Carcinoma Survivors

Contribution of EGFR and ErbB-3 Heterodimerization to the EGFR Mutation-Induced Gefitinib- and Erlotinib-Resistance in Non-Small-Cell Lung Carcinoma Treatments

Safety of two-dose COVID-19 vaccination (BNT162b2 and CoronaVac) in adults with cancer: a territory-wide cohort study

Long-term outcomes and recurrence pattern of 18F-FDG PET-CT complete metabolic response in the first-line treatment of metastatic colorectal cancer: a lesion-based and patient-based analysis

A systematic review and recommendations on the use of plasma EBV DNA for nasopharyngeal carcinoma

Dosimetric Predictors of Radiation-induced Acute Nausea and Vomiting in IMRT for Nasopharyngeal Cancer

Deciphering mechanisms of acquired T790M mutation after EGFR inhibitors for NSCLC by computational simulations

Novel therapy for nasopharyngeal carcinoma – Where are we

The Role of Natural Killer Cells in the Tumor Immune Microenvironment of EBV-Associated Nasopharyngeal Carcinoma

Patterns of care and treatment outcomes for local recurrence of NPC after definite IMRT—A study by the HKNPCSG

EGFR Mutant Structural Database: computationally predicted 3D structures and the corresponding binding free energies with gefitinib and erlotinib

Cost-Effectiveness of Anti-Epidermal Growth Factor Receptor Therapy Versus Bevacizumab in KRAS Wild-Type (WT), Pan-RAS WT, and Pan-RAS WT Left-Sided Metastatic Colorectal Cancer

Direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer-associated venous thrombosis: a cost-effectiveness analysis

Application of Artificial Intelligence for Nasopharyngeal Carcinoma Management - A Systematic Review

Molecular subtyping of cancer: current status and moving toward clinical applications

Clinical utility of plasma Epstein‐Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma

Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma

Whole-Field Simultaneous Integrated-Boost Intensity-Modulated Radiotherapy for Patients With Nasopharyngeal Carcinoma

A Novel DPYD Variant Associated With Severe Toxicity of Fluoropyrimidines: Role of Pre-emptive DPYD Genotype Screening

Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial

Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study)

Considerations for Use of Immune Checkpoint Inhibitors in Cancer Therapy for Patients with Co-Existing Thyroid Eye Disease

Suchergebnisse filtern